This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

DePuy ASR Lawsuit Update: Toxicologist Testifies That Plaintiff Kransky Has High Levels Of Metal In His Blood

Loren Kransky, 65, of North Dakota, alleges that the DePuy ASR caused him metal poisoning, among other problems, according to court records. DePuy asserts that Kransky's health problems are unrelated to his now-removed hip implant, according to Bloomberg.**

"Many people have initiated DePuy ASR lawsuits because they believe their implants have made them sicker," said Rochelle Rottenstein, principal of the Rottenstein Law Group. "It is important that these allegations are thoroughly explored in court."

* courtroomview.com/proceedings/sandra-ellis-loren-kransky-et-al-v-depy-inc-et-al-trial-2013-01-22  ** bloomberg.com/news/2013-01-25/j-j-failed-to-warn-of-hip-implant-s-risks-jurors-told-1-.html

About THE ROTTENSTEIN LAW GROUPThe Rottenstein Law Group is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices. (Attorney advertising. Prior results do not guarantee a similar outcome.)

Contact:The Rottenstein Law Group, LLP Rochelle Rottenstein, Esq.321 W. 44th Street# 804 New York, NY 10036(212) 933-9500 (office phone)(212) 933-9980 (facsimile)rochelle (at) rotlaw (dot) com   http://www.rotlaw.com  http://www.depuyhiprecall.us/

SOURCE The Rottenstein Law Group

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,024.06 +183.54 1.03%
S&P 500 2,108.29 +22.78 1.09%
NASDAQ 5,005.3910 +63.9670 1.29%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs